Profile Not Found.

Selected Publications

2024

Sturek, J. M., Hannan, R. T., Upadhye, A., Otoupalova, E., Faron, E. T., Atya, A. A. E., . . . McNamara, C. A. (2024). A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosis.. bioRxiv. doi:10.1101/2024.04.11.589137

Cox, B. P., Hannan, R. T., Batrash, N., Raichura, P., Sperling, A. I., Shim, Y. M., & Sturek, J. M. (2024). Local, Quantitative Morphometry of Fibroproliferative Lung Injury Using Laminin.. American journal of respiratory cell and molecular biology. doi:10.1165/rcmb.2023-0294ma

Hendrick, J., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., Kadl, A., . . . Petri, W. A. (2024). Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial. OPEN FORUM INFECTIOUS DISEASES, 11(2). doi:10.1093/ofid/ofad630

2023

Jie, S., Narasimhan, H., Cheon, I. S., Qian, W., Hu, S., Parimon, T., . . . Chen, P. (2023). Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19. doi:10.21203/rs.3.rs-3587418/v1

Narasimhan, H., Cheon, I. S., Qian, W., Hu, S., Parimon, T., Li, C., . . . Sun, J. (2023). Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19.. bioRxiv. doi:10.1101/2023.09.13.557622

Hendrick, J., Ma, J., Haughey, H., Coleman, R., Nayak, U., Kadl, A., . . . Petri, W. (2023). Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial. doi:10.1101/2023.09.01.23293947

Mann, B. J., Chhabra, P., Ma, M., Brovero, S. G., Hannan, R. T., Sturek, J. M., . . . Brayman, K. L. (2023). Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist. HELIYON, 9(8). doi:10.1016/j.heliyon.2023.e19226

Cox, B. P., Hannan, R. T., Batrash, N., & Sturek, J. M. (2023). Local, Quantitative Morphometry of Fibroproliferative Lung Injury using Laminin.. bioRxiv. doi:10.1101/2023.06.15.545119

Zhu, B., Wei, X., Narasimhan, H., Qian, W., Zhang, R., Cheon, I. S., . . . Sun, J. (2023). Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19. SCIENCE IMMUNOLOGY, 8(82). doi:10.1126/sciimmunol.adf0348

Self, W. H., Shotwell, M. S., Gibbs, K. W., de Wit, M., Files, D. C., Harkins, M., . . . Collins, S. P. (2023). Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19 Two Randomized Clinical Trials. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 329(14), 1170-1182. doi:10.1001/jama.2023.3546

2022

Budnick, I. M., Oliver, S. F., Barros, A. J., & Sturek, J. M. (2022). Pleural Fluid Analysis in Neutropenia. ANNALS OF THE AMERICAN THORACIC SOCIETY, 19(11), 1946-1948. Retrieved from https://www.webofscience.com/

Sasson, J., Donlan, A. N., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., . . . Petri, W. A. J. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial. OPEN FORUM INFECTIOUS DISEASES, 9(8). doi:10.1093/ofid/ofac343

Sasson, J., Donlan, A. N., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., . . . Petri, W. A. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.. medRxiv. doi:10.1101/2022.03.30.22273194

Sturek, J. M., Thomas, T. A., Gorham, J. D., Sheppard, C. A., Raymond, A. H., Petros De Guex, K., . . . Heysell, S. K. (2022). Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.. Microbiology spectrum, 10(1), e0256021. doi:10.1128/spectrum.02560-21

Daamen, A. R. R., Bachali, P., Bonham, C. A. A., Somerville, L., Sturek, J. M. M., Grammer, A. C. C., . . . Lipsky, P. E. E. (2022). COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity. FRONTIERS IN IMMUNOLOGY, 13. doi:10.3389/fimmu.2022.989556

2021

Self, W. H., Sandkovsky, U., Reilly, C. S., Vock, D. M., Gottlieb, R. L., Mack, M., . . . Lundgren, J. D. (2022). Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. LANCET INFECTIOUS DISEASES, 22(5), 622-635. doi:10.1016/S1473-3099(21)00751-9

Abhyankar, M. M., Mann, B. J., Sturek, J. M., Brovero, S., Moreau, G. B., Sengar, A., . . . Petri, W. A. J. (2021). Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant. NPJ VACCINES, 6(1). doi:10.1038/s41541-021-00399-0

Donlan, A. N., Sutherland, T. E., Marie, C., Preissner, S., Bradley, B. T., Carpenter, R. M., . . . Petri, W. A. J. (2021). IL-13 is a driver of COVID-19 severity. JCI INSIGHT, 6(15). doi:10.1172/jci.insight.150107

Mathews, K. S., Seitz, K. P., Vranas, K. C., Duggal, A., Valley, T. S., Zhao, B., . . . Hough, C. L. (2021). Variation in Initial US Hospital Responses to the Coronavirus Disease 2019 Pandemic*. CRITICAL CARE MEDICINE, 49(7), 1038-1048. doi:10.1097/CCM.0000000000005013

Donlan, A. N., Sutherland, T. E., Marie, C., Preissner, S., Bradley, B. T., Carpenter, R. M., . . . Petri, W. A. (2021). IL-13 is a driver of COVID-19 severity.. medRxiv. doi:10.1101/2020.06.18.20134353

Sturek, J. M., Thomas, T. A., Gorham, J. D., Sheppard, C. A., Raymond, A. E., De Guex, K. P., . . . Heysell, S. K. (2022). Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile. MICROBIOLOGY SPECTRUM, 10(1). Retrieved from https://www.webofscience.com/

Keshavarz, B., Wiencek, J. R., Workman, L. J., Straesser, M. D., Muehling, L. M., Canderan, G., . . . Wilson, J. M. (2021). Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 182(5), 417-424. doi:10.1159/000514203

2020

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 (2021). NEW ENGLAND JOURNAL OF MEDICINE, 384(10), 905-914. doi:10.1056/NEJMoa2033130

Keshavarz, B., Wiencek, J., Bazydlo, L., Straesser, M., Workman, L., Platts-Mills, T., & Wilson, J. (2021). Quantitative Measurement of IgG to SARS-CoV-2 Proteins Using the Phadia ImmunoCAP 250. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 147(2), AB150. Retrieved from https://www.webofscience.com/

Moreau, G. B., Burgess, S. L., Sturek, J. M., Donlan, A. N., Petri, W. A. J., & Mann, B. J. (2020). Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 103(3), 1215-1219. doi:10.4269/ajtmh.20-0762

Upadhye, A., Sturek, J. M., & McNamara, C. A. (2020). 2019 Russell Ross Memorial Lecture in Vascular Biology B Lymphocyte-Mediated Protective Immunity in Atherosclerosis. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 40(2), 309-322. doi:10.1161/ATVBAHA.119.313064

2019

Sturek, J., & Noth, I. (2019). Wandering out of the GWAS wilderness: a new pathway paradigm for complex disease genetics. THORAX, 74(3), 215-216. doi:10.1136/thoraxjnl-2018-212511

Callahan, S. J., Sturek, J. M., & Richard, R. P. (2019). Pulmonary Vasculitides: A Review. Clinical Pulmonary Medicine, 26(1), 10-17. doi:10.1097/cpm.0000000000000290

2018

McKenney-Drake, M. L., Moghbel, M. C., Paydary, K., Alloosh, M., Houshmand, S., Moe, S., . . . Alavi, A. (2018). 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45(12), 2190-2200. doi:10.1007/s00259-018-4078-0

2017

Nunn, A., Sturek, J. M., Reuss, J. E., Rein, M. F., & Heysell, S. K. (2017). Subacute loss of vision in one eye · rash on hands and feet · plaques with scaling on genitals · Dx?. The Journal of family practice, 66(12), E9-E11.

Nunn, A., Sturek, J. M., Reuss, J. E., Rein, M. F., & Heysell, S. K. (2017). THE PATIENT 67-year-old man. JOURNAL OF FAMILY PRACTICE, 66(12), E9-E11. Retrieved from https://www.webofscience.com/

2010

Sturek, J. M., Castle, J. D., Trace, A. P., Page, L. C., Castle, A. M., Evans-Molina, C., . . . Hedrick, C. C. (2010). An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic β cells. JOURNAL OF CLINICAL INVESTIGATION, 120(7), 2575-2589. doi:10.1172/JCI41280

Whetzel, A. M., Sturek, J. M., Nagelin, M. H., Bolick, D. T., Gebre, A. K., Parks, J. S., . . . Hedrick, C. C. (2010). ABCG1 Deficiency in Mice Promotes Endothelial Activation and Monocyte-Endothelial Interactions. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 30(4), 809-U390. doi:10.1161/ATVBAHA.109.199166